Treatment with catalpol protects against cisplatin-induced renal injury through Nrf2 and NF-κB signaling pathways

Cisplatin (CP) is one of the most widely used chemotherapy drugs for cancer treatment, but it often leads to nephrotoxicity. It is well known that catalpol exhibits antioxidant and anti-inflammatory functions, thus the present study aimed to investigate the potential protective effects of catalpol o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jun, Liu, Li, Li, Furong, Wang, Zongqian, Zhao, Jinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444339/
https://www.ncbi.nlm.nih.gov/pubmed/32855669
http://dx.doi.org/10.3892/etm.2020.9077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444339/
https://www.ncbi.nlm.nih.gov/pubmed/32855669
http://dx.doi.org/10.3892/etm.2020.9077

Ejemplares similares